GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » EPS (Basic)

Chandra Bhagat Pharma (BOM:542934) EPS (Basic) : ₹2.10 (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma EPS (Basic)?

Chandra Bhagat Pharma's basic earnings per share (Basic EPS) for the six months ended in Sep. 2024 was ₹0.91. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹2.10.

Chandra Bhagat Pharma's EPS (Diluted) for the six months ended in Sep. 2024 was ₹0.91. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹2.10.

Chandra Bhagat Pharma's EPS without NRI for the six months ended in Sep. 2024 was ₹0.91. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 1.60.

During the past 12 months, Chandra Bhagat Pharma's average EPS without NRIGrowth Rate was -33.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 77.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Chandra Bhagat Pharma's highest 3-Year average EPS without NRI Growth Rate was 77.90% per year. The lowest was -41.80% per year. And the median was 33.90% per year.


Chandra Bhagat Pharma EPS (Basic) Historical Data

The historical data trend for Chandra Bhagat Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma EPS (Basic) Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS (Basic)
Get a 7-Day Free Trial 0.55 0.25 1.06 1.20 2.03

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.71 0.84 1.19 0.91

Chandra Bhagat Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Chandra Bhagat Pharma's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(15.303-0)/7.545
=2.03

Chandra Bhagat Pharma's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6.849-0)/7.526
=0.91

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chandra Bhagat Pharma  (BOM:542934) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Chandra Bhagat Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Chandra Bhagat Pharma Business Description

Traded in Other Exchanges
N/A
Address
Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma Headlines

No Headlines